T 1032/09 (Dosage form comprising a proton pump inhibitor and a NSAID/ASTRAZENECA) of 26.09.2014

European Case Law Identifier: ECLI:EP:BA:2014:T103209.20140926
Date of decision: 26 September 2014
Case number: T 1032/09
Petition for review of: -
Application number: 03011903.6
IPC class: A61K 45/06 A61K 9/26 A61K 31/4439 A61K 31/5415 A61K 31/196 A61K 9/54
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING A PROTON PUMP INHIBITOR AND A NSAID
Applicant name: AstraZeneca AB
Opponent name: -
Board: 3.3.02
Headnote: -
Relevant legal provisions: European Patent Convention Art 76(1)Rules of procedure of the Boards of Appeal Art 12Rules of procedure of the Boards of Appeal Art 15(1)Rules of procedure of the Boards of Appeal Art 15(3)
Keywords: Oral proceedings - held in absence of appellant
Divisional application - added subject-matter (yes)
Catchword: -
Cited cases: G 0004/92 G 0010/93
Citing cases: -

Order

For these reasons it is decided that:

The appeal is dismissed.